Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2846385612;85613;85614 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
N2AB2682280689;80690;80691 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
N2A2589577908;77909;77910 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
N2B1939858417;58418;58419 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
Novex-11952358792;58793;58794 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
Novex-21959058993;58994;58995 chr2:178560745;178560744;178560743chr2:179425472;179425471;179425470
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTC
  • RefSeq wild type template codon: GAG
  • Domain: Fn3-95
  • Domain position: 14
  • Structural Position: 15
  • Q(SASA): 0.3904
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F None None 0.988 N 0.663 0.257 0.625243557465 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
L/R None None 0.994 N 0.799 0.448 0.763205773721 gnomAD-4.0.0 1.59144E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85807E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.3476 ambiguous 0.3934 ambiguous -1.419 Destabilizing 0.938 D 0.499 neutral None None None None N
L/C 0.4196 ambiguous 0.4718 ambiguous -0.935 Destabilizing 1.0 D 0.713 prob.delet. None None None None N
L/D 0.7852 likely_pathogenic 0.8283 pathogenic -0.717 Destabilizing 0.998 D 0.821 deleterious None None None None N
L/E 0.4734 ambiguous 0.5355 ambiguous -0.76 Destabilizing 0.995 D 0.811 deleterious None None None None N
L/F 0.1703 likely_benign 0.1885 benign -1.25 Destabilizing 0.988 D 0.663 neutral N 0.489468191 None None N
L/G 0.6358 likely_pathogenic 0.6931 pathogenic -1.685 Destabilizing 0.995 D 0.809 deleterious None None None None N
L/H 0.3461 ambiguous 0.4013 ambiguous -0.998 Destabilizing 0.999 D 0.809 deleterious N 0.471661954 None None N
L/I 0.0726 likely_benign 0.0758 benign -0.792 Destabilizing 0.825 D 0.435 neutral N 0.375486537 None None N
L/K 0.284 likely_benign 0.3352 benign -0.809 Destabilizing 0.995 D 0.789 deleterious None None None None N
L/M 0.128 likely_benign 0.1363 benign -0.554 Destabilizing 0.995 D 0.685 prob.neutral None None None None N
L/N 0.4954 ambiguous 0.5699 pathogenic -0.553 Destabilizing 0.998 D 0.817 deleterious None None None None N
L/P 0.3946 ambiguous 0.4138 ambiguous -0.968 Destabilizing 0.998 D 0.822 deleterious N 0.470901485 None None N
L/Q 0.2284 likely_benign 0.2743 benign -0.792 Destabilizing 0.998 D 0.796 deleterious None None None None N
L/R 0.2356 likely_benign 0.2778 benign -0.245 Destabilizing 0.994 D 0.799 deleterious N 0.462396233 None None N
L/S 0.4265 ambiguous 0.503 ambiguous -1.163 Destabilizing 0.995 D 0.785 deleterious None None None None N
L/T 0.2462 likely_benign 0.295 benign -1.09 Destabilizing 0.991 D 0.68 prob.neutral None None None None N
L/V 0.0793 likely_benign 0.0821 benign -0.968 Destabilizing 0.067 N 0.165 neutral N 0.33573607 None None N
L/W 0.3345 likely_benign 0.377 ambiguous -1.261 Destabilizing 1.0 D 0.776 deleterious None None None None N
L/Y 0.4173 ambiguous 0.4656 ambiguous -1.013 Destabilizing 0.995 D 0.769 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.